Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
US5512549A · kind A · utility
233Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 1994 |
| Grant date | Apr 30, 1996 |
| Priority date | — |
| Expiry date | Oct 18, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/915
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glucagon-like insulinotropic peptide (GLP-1(7-37)) analogs and derivatives are disclosed. The analogs include amino acid substitutions, amino and carboxyl terminal modifications, and C.sub.6 -C.sub.10 acylations. The claimed compounds stimulate the secretion or biosynthesis of insulin in poorly functioning beta cells and are therefore useful in treating Type II diabetics
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.